Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Cazzaniga

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial InfectionsMatteo Mori, Giovanni Stelitano, Anna Griego, et al.
European Journal of Medicinal Chemistry|January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessusMatteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
Pharmaceutics|February 25, 2023
Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous MycobacteriaMatteo Mori, Giovanni Stelitano, Giulia Cazzaniga, et al.
Journal of Medicinal Chemistry|March 3, 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis TherapyGiulia Cazzaniga, Matteo Mori, Anna Griego, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial InfectionsMatteo Mori, Giovanni Stelitano, Anna Griego, et al.
European Journal of Medicinal Chemistry|January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessusMatteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
Pharmaceutics|February 25, 2023
Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous MycobacteriaMatteo Mori, Giovanni Stelitano, Giulia Cazzaniga, et al.
Journal of Medicinal Chemistry|March 3, 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis TherapyGiulia Cazzaniga, Matteo Mori, Anna Griego, et al.
Pageof 2